-
Sponsored by Fellner Wratzfeld & PartnersRestructuring activity has also increased as the retail, real estate, and construction sectors struggle to cope with recent crises and rising costs, say Markus Fellner, Florian Henöckl, and Nadine Maros of Fellner Wratzfeld & Partners
-
Sponsored by Bär & KarrerChristoph Neeracher, Luca Jagmetti, and Thomas Rohde of Bär & Karrer discuss Switzerland’s restructuring and insolvency landscape for 2024 and beyond
-
Sponsored by JeantetThe system has proved to be effective in addressing companies with business difficulties, but areas of uncertainty remain, say Laïd Estelle Laurent, Jean Delapalme, and Claire Blondel of Jeantet
-
Sponsored by LPA-CGR avocatsThe key components of a business-friendly environment are in place in France and present an opportunity for further Chinese investment, say Raphaël Chantelot, Ran Hu, and Hubert Bazin of LPA-CGR avocats
-
Sponsored by Eng and Co.Rather than being seen solely as a burden, climate-related disclosures may represent an opportunity for proactive companies to secure a competitive advantage, say Rachel Eng and Pei Yin Yap of Eng and Co.
-
Sponsored by Papapolitis & PapapolitisElena Papachristou and Maria-Roxani Karydi of Papapolitis & Papapolitis say increased activity can be expected in the Greek capital market as certain companies consider how to address new free float requirements, among other regulatory changes
-
Sponsored by HomburgerA Swiss Federal Council report containing recommendations on improving financial market stability requires further evaluation, including with respect to the design of future additional tier 1 capital instruments, say Stefan Kramer, Benedikt Maurenbrecher, and Daniel Hulmann of Homburger
-
Sponsored by Riquito AdvogadosJoão Nuno Riquito and Belmiro Leong of Riquito Advogados explain quasi-capital contributions and why this financing instrument, as opposed to traditional means, can safeguard the interests of a company, its shareholders, and its creditors
-
Sponsored by GSK StockmannMarcus Peter and Kate Yu Rao of GSK Stockmann provide a guide to the most recent legal and regulatory developments impacting Chinese investments into Luxembourg